-
Labeling for the European levonorgestrel (LNG) emergency contraceptive pill NorLevo has been revised due to data indicating lower drug efficacy in women weighing 165 pounds and above. This move has led U.S. regulators to assess data on similar products.
-
The Bill & Melinda Gates Foundation has just released funding to support 11 projects that aim to improve uptake and regular use of male and female condoms by developing new designs that significantly preserve or enhance pleasure and simplify use.
-
-
-
A review of 10 years of national data indicates that clinicians have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women: those who have undergone hysterectomies and those older than age 65 with no cervical cancer history.
-
Results of the 2013 Contraceptive Technology Update Contraception Survey indicate that use of the NuvaRing contraceptive vaginal ring and the Evra contraceptive patch is consistent with 2012's figures.
-
Responses to the 2013 Contraceptive Technology Update Contraception Survey indicate that many clinicians have moved to remove one hurdle to contraception by adopting the Quick Start method of method initiation.
-
Women continue to choose long-acting reversible contraceptive (LARC) methods, say respondents to the 2013 Contraceptive Technology Update Contraception Survey.
-
Intimate partner violence (IPV) and reproductive and sexual coercion disproportionately affect women. Such behavior is aimed at establishing control of one partner over the other.
-
According to results from the 2013 Contraceptive Technology Update Contraception Survey, while many women continue to pick combined oral contraceptives (OCs), other options are making inroads on the popular choice.